![](/img/cover-not-exists.png)
722PA phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: Primary analysis results
Ikeda, M., Sasaki, T., Morizane, C., Mizuno, N., Nagashima, F., Shimizu, S., Hayata, N., Ikezawa, H., Suzuki, T., Nakajima, R., Dutcus, C., Ueno, M.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.106
Date:
September, 2017
File:
PDF, 47 KB
english, 2017